Waist-to-Height Ratio Best Predictor of Metabolic Syndrome
Metabolic Syndrome was present in 74.5% of the cohort.
Metabolic Syndrome was present in 74.5% of the cohort.
Wow! This is the first wordI think of to describe therecent announcement ofthe early termination of the SystolicBlood Pressure Intervention Trial(SPRINT) sponsored by the NationalInstitutes of Health (NIH). The studybegan in the fall of 2009 and includedmore than 9,300 participants aged50 years and older from about 100medical centers in the United Statesand Puerto Rico. The…
Highest vs. lowest quartile associated with a 17% increased risk.
Analytic sample of 692 men wearing ActiGraph 7164 accelerometer confirms inverse association.
Cisplatin-based chemotherapy after radical cystectomy for high-risk bladder cancer decreased the risk of death from the malignancy by 29%.
ABO blood may be useful in risk-stratification of patients who may benefit from more aggressive treatment and/or altered surveillance regimens.
It reduces dose requirements and lowers the risk of death and hospitalization for cardiovascular complications compared with IV administration.
Population-based Australian data from 2001-2009 show better 5-year disease-specific and overall survival rates compared with older studies.
Over 3 years after radical surgery, men who delayed surgery and those who had immediate surgery had similar rates of biochemical recurrence.
New study also shows that uncontrolled vs. controlled resistant hypertension increases ESRD and cerebrovascular accident risk.